Ocular drug delivery: present innovations and future challenges

Ranibizumab for Neovascular Age-Related Macular Degeneration

Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886 · see citing works

Pegaptanib for neovascular age-related macular degeneration

Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · see citing works

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,602 · see citing works

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,591 · see citing works

Ocular drug delivery

Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9183-3 · Cited by 1,406 · see citing works

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L. M., Ferrara, N., King, G. L., & Smith, L. E. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,258 · see citing works

Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Boyer, D. S., Yoon, Y. H., Belfort, R., Bandello, F. M., Maturi, R. K., Augustin, A. J., Li, X., Cui, H., Hashad, Y., & Whitcup, S. M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.024 · Cited by 1,125 · see citing works

Dissolving microneedles for transdermal drug delivery

Lee, J. W., Park, J., & Prausnitz, M. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.048 · Cited by 975 · see citing works

Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion

Haller, J. A., Bandello, F. M., Belfort, R., Blumenkranz, M. S., Gillies, M. C., Heier, J. S., Loewenstein, A., Yoon, Y. H., Jiao, J., Li, X.-Y., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.05.014 · Cited by 672 · see citing works

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A

de Campos, Á. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 667 · see citing works

Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman Primate

Adamis, A. P. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130062010 · Cited by 630 · see citing works

Determination of tear volume and tear flow.

Mishima, S., Gasset, A. R., Klyce, S. D., & BAUM, J. L. (1966) · PubMed · Cited by 607 · see citing works

Transdifferentiated Retinal Pigment Epithelial Cells are Immunoreactive for Vascular Endothelial Growth Factor in Surgically Excised AgeRelated Macular Degeneration-Related Choroidal Neovascular Membranes.

Lopez, P. F., Sippy, B., Lambert, H. M., Thach, A. B., & Hinton, D. R. (1998) · Retina · doi:10.1097/00006982-199805000-00035 · Cited by 592 · see citing works

Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants

Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591 · see citing works

Recent advances in the use of cell-penetrating peptides for medical and biological applications☆

Fonseca, S. B., Pereira, M. P., & Kelley, S. O. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.001 · Cited by 553 · see citing works

Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

Campochiaro, P. A., Brown, D. M., Pearson, P. A., Chen, S., Boyer, D. S., Ruiz‐Moreno, J. M., Garretson, B. R., Gupta, A., Hariprasad, S. M., Bailey, C., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.030 · Cited by 517 · see citing works

Topical Ocular Drug Delivery: Recent Developments and Future Challenges

Lee, V. H. L., & Robinson, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 504 · see citing works

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481 · see citing works

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

Aliello, L. P. (1995) · Medical Entomology and Zoology · Cited by 463 · see citing works

Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis

Jaffe, G. J., Martin, D. F., Callanan, D., et al. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.02.021 · Cited by 455 · see citing works

Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases

Bachu, R. D., Chowdhury, P., Al-Saedi, Z. H. F., Karla, P. K., & Boddu, S. H. S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010028 · Cited by 425 · see citing works

Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors

Huang, H.-S., & Schoenwald, R. D. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721108 · Cited by 422 · see citing works

Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide

Vandamme, T. F., & Brobeck, L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 402 · see citing works

Topical and systemic drug delivery to the posterior segments

HUGHES, P., OLEJNIK, O., Chang-Lin, J.-E., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400 · see citing works

Corneal Neovascularization: An Anti-VEGF Therapy Review

Chang, J., Garg, N. K., Lunde, E., Han, K., Jain, S. K., & Azar, D. T. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.007 · Cited by 385 · see citing works

Nanotechnology-based strategies for treatment of ocular disease

Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 376 · see citing works

Untitled work

(2000) · PubMed · Cited by 358 · see citing works

Lacrimal and Instilled Fluid Dynamics in Rabbit Eyes

Chrai, S. S., Patton, T. F., Mehta, A., et al. (1973) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600620712 · Cited by 354 · see citing works

Chitosan-based nanostructures: A delivery platform for ocular therapeutics

de la Fuente, M., Raviña, M., Paolicelli, P., Sánchez, A., Seijo, B., & Alonso, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.026 · Cited by 354 · see citing works

Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen

Pignatello, R., Bucolo, C., Ferrara, P., Maltese, A., Puleo, A., & Puglisi, G. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00057-x · Cited by 350 · see citing works

Comparisons of the Intraocular Tissue Distribution, Pharmacokinetics, and Safety of 125I-Labeled Full-Length and Fab Antibodies in Rhesus Monkeys Following Intravitreal Administration

Mordenti, J. J., Cuthbertson, R. A., Ferrara, N., Thomsen, K., Berleau, L. T., Ličko, V., Allen, P. C., Valverde, C. R., Meng, Y. G., Fei, D. T. W., et al. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700507 · Cited by 350 · see citing works

Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery

Than, A., Liu, C., Chang, H., Duong, P. K., Cheung, C. M. G., Xu, C., Wang, X., & Chen, P. (2018) · Nature Communications · doi:10.1038/s41467-018-06981-w · Cited by 347 · see citing works

Recent advances in ocular drug delivery

Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.736515 · Cited by 335 · see citing works

Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial

Kempen, J. H., Altaweel, M. M., Holbrook, J. T., Jabs, D. A., Louis, T. A., Sugar, E. A., & Thorne, J. E. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.07.027 · Cited by 333 · see citing works

Suprachoroidal drug delivery to the back of the eye using hollow microneedles

Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330 · see citing works

Ocular Preparations: The Formulation Approach

Kaur, I. P., & Kanwar, M. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120003445 · Cited by 310 · see citing works

Ophthalmic Drug Delivery through Contact Lenses

Gulsen, D., & Chauhan, A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0959 · Cited by 305 · see citing works

Cyclodextrins in ophthalmic drug delivery

Loftssona, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00055-6 · Cited by 305 · see citing works

Comparative in vitro Evaluation of Several Colloidal Systems, Nanoparticles, Nanocapsules, and Nanoemulsions, as Ocular Drug Carriers

Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950474+ · Cited by 303 · see citing works

Growth factor localization in choroidal neovascular membranes of age-related macular degeneration.

Amin, R., Puklin, J. E., & Frank, R. N. (1994) · PubMed · Cited by 299 · see citing works

Cell culture models of the ocular barriers

Hornof, M., Toropainen, E., & Urtti, A. O. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.009 · Cited by 299 · see citing works

Recent Advances in Ophthalmic Drug Delivery

Kompella, U. B., Kadam, R. S., & Lee, V. H. L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.40 · Cited by 291 · see citing works

Coated Microneedles for Drug Delivery to the Eye

Jiang, J., Gill, H. S., Ghate, D. A., McCarey, B. E., Patel, S. R., Edelhauser, H. F., & Prausnitz, M. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0066 · Cited by 286 · see citing works

Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application

Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 284 · see citing works

Drop Size and Initial Dosing Frequency Problems of Topically Applied Ophthalmic Drugs

Chrai, S. S., Makoid, M. C., Eriksen, S. P., et al. (1974) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600630304 · Cited by 255 · see citing works

INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS

PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255 · see citing works

A Drug-Eluting Contact Lens

Ciolino, J. B., Hoare, T. R., Iwata, N. G., Behlau, I., Dohlman, C. H., Langer, R., & Kohane, D. S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2826 · Cited by 248 · see citing works

Targeted Administration into the Suprachoroidal Space Using a Microneedle for Drug Delivery to the Posterior Segment of the Eye

Patel, S. R., Berezovsky, D. E., McCarey, B. E., Zarnitsyn, V. G., Edelhauser, H. F., & Prausnitz, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9872 · Cited by 242 · see citing works

Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application

Tsai, C.-H., Wang, P., Lin, I., Hu, H., Liu, G., & Tseng, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092830 · Cited by 241 · see citing works

Drug delivery systems for vitreoretinal diseases

Yasukawa, T., Ogura, Y., Tabata, Y., Kimura, H., Wiedemann, P., & Honda, Y. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.02.003 · Cited by 232 · see citing works

Overcoming ocular drug delivery barriers through the use of physical forces

Huang, D., Chen, Y.-S., & Rupenthal, I. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.008 · Cited by 230 · see citing works

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches

Mandal, A., Pal, D., Agrahari, V., Trinh, H. M., Joseph, M. A., & Mitra, A. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.008 · Cited by 224 · see citing works

Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease

Sheppard, J. D., Torkildsen, G. L., Lonsdale, J. D., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.015 · Cited by 220 · see citing works

Novel approaches to retinal drug delivery

Janoria, K. G., Gunda, S., Boddu, S. H. S., & Mitra, A. K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.371 · Cited by 213 · see citing works

Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow

Ali, M., Horikawa, S., Venkatesh, S., Saha, J., Hong, J. W., & Byrne, M. E. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.006 · Cited by 211 · see citing works

Acyclovir-containing liposomes for potential ocular delivery

Law, S. L., Huang, K.-J., & Chiang, C. ‐. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00192-3 · Cited by 202 · see citing works

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease

Tauber, J., Karpecki, P. M., Latkany, R. A., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.08.001 · Cited by 202 · see citing works

Nanocarriers in Ocular Drug Delivery: An Update Review

Wadhwa, S., Paliwal, R., Paliwal, S. R., & Vyas, S. P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788923886 · Cited by 196 · see citing works

Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery

Cholkar, K., Patel, A., Vadlapudi, A. D., & Mitra, A. K. (2012) · Current Nanomedicine · doi:10.2174/1877912311202020082 · Cited by 193 · see citing works

Transscleral delivery of bioactive protein to the choroid and retina.

Ambati, J., Gragoudas, E. S., Miller, J. W., You, T., Miyamoto, K., Delori, F. C., & Adamis, A. P. (2000) · PubMed · Cited by 189 · see citing works

Novel Strategies for Anterior Segment Ocular Drug Delivery

Cholkar, K., Patel, S. P., Vadlapudi, A. D., & Mitra, A. K. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0200 · Cited by 189 · see citing works

Sustained Ocular Drug Delivery from a Temperature and pH Triggered Novel In Situ Gel System

Gupta, H., Jain, S., Mathur, R., et al. (2007) · Drug Delivery · doi:10.1080/10717540701606426 · Cited by 187 · see citing works

Nanomaterials for Ocular Drug Delivery

Liu, S., Jones, L., & Gu, F. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201100419 · Cited by 185 · see citing works

Nanotherapies for the treatment of ocular diseases

Reimóndez-Troitiño, S., Csaba, N., Alonso, M. J., & de la Fuente, M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.019 · Cited by 183 · see citing works

Ocular Drug Delivery

Schoenwald, R. D. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018040-00001 · Cited by 183 · see citing works

Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications

Chaniotakis, N. A., Thermos, K., & Kalomiraki, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s93069 · Cited by 181 · see citing works

Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy

Yuan, X., Marcano, D. C., Shin, C. S., Hua, X., Isenhart, L. C., Pflugfelder, S. C., & Acharya, G. S. (2015) · ACS Nano · doi:10.1021/nn506599f · Cited by 180 · see citing works

Recent Advances in Topical Ocular Drug Delivery

Yellepeddi, V., & Palakurthi, S. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2015.0047 · Cited by 179 · see citing works

Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review

Dubald, M., Bourgeois, S., Andrieu, V., & Fessi, H. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10010010 · Cited by 176 · see citing works

Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye

Loftsson, Þ., & Stefánsson, E. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800205.x · Cited by 174 · see citing works

Minimally invasive microneedles for ocular drug delivery

Singh, R. R. T., Tekko, I. A., McAvoy, K., McMillan, H. L., Jones, D. S., & Donnelly, R. F. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218460 · Cited by 173 · see citing works

Industrial perspective in ocular drug delivery

Ali, Y., & Lehmussaari, K. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.022 · Cited by 172 · see citing works

Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment

Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171 · see citing works

Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation

Soiberman, U., Kambhampati, S. P., Wu, T., Mishra, M. K., Oh, Y., Sharma, R. B., Wang, J., Towerki, A. E. A., Yiu, S. C., Stark, W. J., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.016 · Cited by 170 · see citing works

A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits

Kamei, M., Misono, K., & Lewis, H. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00239-1 · Cited by 169 · see citing works

Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5‐associated Liposomes

Davis, B. M., Normando, E. M., Guo, L., Turner, L., Nizari, S., O’Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 165 · see citing works

Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease

Mandal, A., Gote, V., Pal, D., Ogundele, A., & Mitra, A. K. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2556-5 · Cited by 162 · see citing works

Treatment of Acute Posterior Uveitis in a Porcine Model by Injection of Triamcinolone Acetonide Into the Suprachoroidal Space Using Microneedles

Gilger, B. C., Abarca, E. M., Salmon, J. H., & Patel, S. R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11747 · Cited by 157 · see citing works

Sustained Delivery Fluocinolone Acetonide Vitreous Implants

Cunha-Vaz, J. G., Ashton, P., Iezzi, R., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.04.019 · Cited by 157 · see citing works

Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study

Kinoshita, S., Awamura, S., Oshiden, K., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.06.052 · Cited by 149 · see citing works

Human Retinal Molecular Weight Exclusion Limit and Estimate of Species Variation

Jackson, T. L., Antcliff, R. J., Hillenkamp, J., & Marshall, J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1027 · Cited by 145 · see citing works

Aflibercept for neovascular age-related macular degeneration

Sarwar, S., Clearfield, E., Soliman, M. K., Sadiq, M. A., Baldwin, A. J., Hanout, M., Agarwal, A., Sepah, Y. J., Do, D. V., & Nguyen, Q. D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011346.pub2 · Cited by 142 · see citing works

Advances in ocular drug delivery: emphasis on the posterior segment

Kang‐Mieler, J. J., Osswald, C. R., & Mieler, W. F. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.935338 · Cited by 142 · see citing works

Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration

Qiu, F., Meng, T., Chen, Q., Zhou, K., Shao, Y. X., Greg, M. H., Ma, X., Wu, W., Du, Y., Wang, X., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01319 · Cited by 131 · see citing works

A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles

Sousa, F., Cruz, A., Fonte, P., Pinto, I. M., Neves‐Petersen, M. T., & Sarmento, B. F. C. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-03959-4 · Cited by 128 · see citing works

In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles

Liaw, J., Chang, S.-F., & Hsiao, F.-C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301485 · Cited by 125 · see citing works

Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation

Rodrigues, G. A., Lutz, D., Shen, J., Yuan, X., Shen, H., Cunningham, J., & Rivers, H. M. (2018) · Pharmaceutical Research · doi:10.1007/s11095-018-2519-x · Cited by 125 · see citing works

Latanoprost in the treatment of glaucoma

Stolz, J., & Alm, A. (2014) · Clinical ophthalmology · doi:10.2147/opth.s59162 · Cited by 124 · see citing works

Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye

Sigurðsson, H. H., Konrádsdóttir, F., Loftsson, Þ., & Stefánsson, E. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00885.x · Cited by 122 · see citing works

Sustained release intraocular drug delivery devices for treatment of uveitis.

Haghjou, N., Soheilian, M., & Abdekhodaie, M. J. (2011) · Europe PMC (PubMed Central) · Cited by 121 · see citing works

Randomized clinical trial of a new dexamethasone delivery system (surodex) for treatment of post-cataract surgery inflammation11The authors have no financial interest in this or competing products or in Surodex or Oculex Pharmaceuticals, Inc.

Tan, D. T. H., Chee, S.-P., Lim, L., et al. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90060-x · Cited by 121 · see citing works

PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab

Elsaid, N., Jackson, T. L., Elsaid, Z., Alqathama, A. A., & Somavarapu, S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00335 · Cited by 121 · see citing works

Transscleral drug delivery to the retina and choroid

Ambati, J., & Adamis, A. P. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00018-0 · Cited by 119 · see citing works

Liposomal voriconazole (VOR) formulation for improved ocular delivery

de Sá, F. A. P., Taveira, S. F., Gelfuso, G. M., Lima, E. M., & Gratieri, T. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.06.036 · Cited by 117 · see citing works

Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea

Sharma, A., Tandon, A., Tovey, J. C. K., Gupta, R., Robertson, J. D., Fortune, J. A., Klibanov, A. M., Cowden, J. W., Rieger, F. G., & Mohan, R. R. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.006 · Cited by 117 · see citing works

Adverse events with silicone hydrogel continuous wear

Dumbleton, K. (2002) · Contact Lens and Anterior Eye · doi:10.1016/s1367-0484(02)00009-7 · Cited by 114 · see citing works

Ocular Drug Delivery: Nanomedicine Applications

Vandervoort, J., & Ludwig, A. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.11 · Cited by 114 · see citing works

Application of encapsulated cell technology for retinal degenerative diseases

Tao, W. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.7.717 · Cited by 108 · see citing works

Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model

Olsen, T. W., Feng, X., Wabner, K., Csaky, K., Pambuccian, S., & Cameron, J. D. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6291 · Cited by 106 · see citing works

Bioinspired hydrogels for drug-eluting contact lenses

Alvarez‐Lorenzo, C., Anguiano-Igea, S., Varela-García, A., Vivero-Lopez, M., & Concheiro, Á. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.11.020 · Cited by 106 · see citing works

Dexamethasone nanowafer as an effective therapy for dry eye disease

Coursey, T. G., Henriksson, J. T., Marcano, D. C., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.007 · Cited by 105 · see citing works

Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery

Song, H. B., Lee, K., Seo, I. H., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.041 · Cited by 102 · see citing works

Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain

Korenfeld, M. S., Silverstein, S., Cooke, D. L., Vogel, R., & Crockett, R. S. (2008) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2008.09.024 · Cited by 102 · see citing works

Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides

de Cogan, F., Hill, L. J., Lynch, A., Morgan-Warren, P. J., Lechner, J., Berwick, M. R., Peacock, A. F. A., Chen, M., Scott, R. A. H., Xu, H., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20072 · Cited by 101 · see citing works

In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model

Li, G., Lee, C.-Y., Agrahari, V., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814889116 · Cited by 101 · see citing works

Ocular neovascularization: a valuable model system

Campochiaro, P. A., & Hackett, S. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206773 · Cited by 100 · see citing works

Randomized clinical trial of surodex steroid drug delivery system for cataract surgery Anterior versus posterior placement of two surodex in the eye

Tan, D. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00839-9 · Cited by 99 · see citing works

Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability.

Nicoli, S., Ferrari, G., Quarta, M., Macaluso, C., Govoni, P., Dallatana, D., & Santi, P. (2009) · PubMed Central · Cited by 99 · see citing works

Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges

Molokhia, S. A., Thomas, S., Garff, K. J., Mandell, K. J., & Wirostko, B. M. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0241 · Cited by 98 · see citing works

Epigalloccatechin-3-gallate Inhibits Ocular Neovascularization and Vascular Permeability in Human Retinal Pigment Epithelial and Human Retinal Microvascular Endothelial Cells via Suppression of MMP-9 and VEGF Activation

Lee, H. S., Jun, J.-H., Jung, E., et al. (2014) · Molecules · doi:10.3390/molecules190812150 · Cited by 97 · see citing works

Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines

Burgalassi, S., Chetoni, P., Monti, D., et al. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00261-2 · Cited by 96 · see citing works

Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo studies

Akhter, S., Anwar, M., Siddiqui, M. A., et al. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.08.048 · Cited by 96 · see citing works

A Nonionic Surfactant/Chitosan Micelle System in an Innovative Eye Drop Formulation

Pepić, I., Hafner, A., Lovrić, J., Pirkić, B., & Filipović‐Grčić, J. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22137 · Cited by 94 · see citing works

Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells.

Contreras‐Ruiz, L., de la Fuente, M., Párraga, J. E., López‐García, A., Fernández, I., Seijo, B., Sánchez, A., Calonge, M., & Diebold, Y. (2011) · PubMed Central · Cited by 93 · see citing works

Tolerance of Ocular Iontophoresis in Healthy Volunteers

Parkinson, T. M., Ferguson, E. H., Febbraro, S., et al. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803321637672 · Cited by 89 · see citing works

NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells.

Emerich, D. F., & Thanos, C. G. (2008) · PubMed · Cited by 85 · see citing works

Ocular biocompatibility of novel cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers

Di Tommaso, C., Torriglia, A., Furrer, P., Behar-Cohen, F., Gurny, R., & Möller, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.004 · Cited by 84 · see citing works

Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir

Tirucherai, G., & Mitra, A. K. (2003) · AAPS PharmSciTech · doi:10.1208/pt040345 · Cited by 81 · see citing works

In vitro , ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration

Cañadas, C., Alvarado, H. L., Calpena, A. C., et al. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.07.055 · Cited by 79 · see citing works

Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model.

Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77 · see citing works

Dendrimers for ocular drug delivery

Lancina, M. G., & Yang, H. (2017) · Canadian Journal of Chemistry · doi:10.1139/cjc-2017-0193 · Cited by 76 · see citing works

Thyroglobulin structure and function: recent advances

Malthièry, Y., Marriq, C., Bergé‐Lefranc, J., Franc, J., Henry, M., Lejeune, P.-J., Ruf, J., & Lissitzky, S. (1989) · Biochimie · doi:10.1016/0300-9084(89)90057-6 · Cited by 75 · see citing works

Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye

Ren, T., Lin, X., Zhang, Q., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00516 · Cited by 74 · see citing works

Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin

Johnson, L. N., Cashman, S. M., Read, S. P., & Kumar‐Singh, R. (2009) · Vision Research · doi:10.1016/j.visres.2009.08.028 · Cited by 72 · see citing works

Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication

Hathout, R. M., Gad, H. A., Abdel-Hafez, S. M., Nasser, N., Mahdy, N. K., Ateyya, T., Amr, A., Yasser, N., Nasr, S., & Metwally, A. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.015 · Cited by 72 · see citing works

Eye drop delivery of nano‐polymeric micelle formulated genes with cornea‐specific promoters

Tong, Y.-C., Chang, S., Liu, C., Kao, W. W. ‐., Huang, C. H., & Liaw, J. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1093 · Cited by 71 · see citing works

Topical administration of a multi‐targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema

Doukas, J., Mahesh, S. P., Umeda, N., Kachi, S., Akiyama, H., Yokoi, K., Cao, J., Chen, Z., Dellamary, L. A., Tam, B. Y. Y., et al. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21426 · Cited by 70 · see citing works

Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye

Fangueiro, J. F., Veiga, F., Silva, A. M., & Souto, E. B. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666151216145900 · Cited by 70 · see citing works

Basic principles and current status of transcorneal and transscleral iontophoresis

Gratieri, T., Santer, V., & Kalia, Y. N. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1266334 · Cited by 69 · see citing works

Dexamethasone – PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation

Yavuz, B., Pehlivan, S. B., Bolu, B. S., Nomak, R., Vural, İ., & Ünlü, N. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12587 · Cited by 63 · see citing works

Cell‐penetrating peptide TAT‐mediated delivery of acidic FGF to retina and protection against ischemia–reperfusion injury in rats

Wang, Y., Lin, H., Lin, S., Qu, J., Xiao, J., Huang, Y., Xiao, Y., Fu, X., Yang, Y., & Li, X. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00786.x · Cited by 62 · see citing works

Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles – Closing the gap in retinal ischaemia

Chen, Y.-S., Green, C. R., Wang, K., Danesh-Meyer, H. V., & Rupenthal, I. D. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.005 · Cited by 61 · see citing works

Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection

Chiang, B., Venugopal, N., Edelhauser, H. F., & Prausnitz, M. R. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.10.011 · Cited by 60 · see citing works

Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery

Mandal, A., Cholkar, K., Khurana, V., Shah, A., Agrahari, V., Bisht, R., Pal, D., & Mitra, A. K. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00128 · Cited by 60 · see citing works

Therapeutic contact lenses: a patent review

Dixon, P., Shafor, C. S., Gause, S., Hsu, K.-H., Powell, K. C., & Chauhan, A. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1057501 · Cited by 59 · see citing works

Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits.

Liang, H., Brignole‐Baudouin, F., Rabinovich‐Guilatt, L., Mao, Z., Riancho, L., Faure, M.-O., Warnet, J., Lambert, G., & Baudouin, C. (2008) · PubMed Central · Cited by 58 · see citing works

Injectable cell-encapsulating composite alginate-collagen platform with inducible termination switch for safer ocular drug delivery

Wong, F. S. Y., Tsang, K. K., Chu, A. M. W., Chan, B. P., Yao, K. M., & Lo, A. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.032 · Cited by 58 · see citing works

New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system

Cao, F., Zhang, X., & Ping, Q. N. (2010) · Drug Delivery · doi:10.3109/10717544.2010.483255 · Cited by 56 · see citing works

Effects of Three Penetration Enhancers on Transcorneal Permeation of Cyclosporine

van der Bijl, P., Eyk, A. D. V., & Meyer, D. (2001) · Cornea · doi:10.1097/00003226-200107000-00013 · Cited by 54 · see citing works

Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide

Sun, Y., Fox, T. E., Adhikary, G., et al. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108076 · Cited by 53 · see citing works

Dexamethasone Drug Eluting Nanowafers Control Inflammation in Alkali-Burned Corneas Associated With Dry Eye

Bian, F., Shin, C. S., Wang, C., Pflugfelder, S. C., Acharya, G. S., & de Paiva, C. S. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19074 · Cited by 52 · see citing works

Corneal Absorption and Anterior Chamber Pharmacokinetics of Dipeptide Monoester Prodrugs of Ganciclovir (GCV): In Vivo Comparative Evaluation of These Prodrugs with Val-GCV and GCV in Rabbits

Gunda, S., Hariharan, S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.465 · Cited by 52 · see citing works

Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population

Sangwan, V., Pearson, P. A., Paul, H., et al. (2014) · Ophthalmology and Therapy · doi:10.1007/s40123-014-0027-6 · Cited by 50 · see citing works

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody

Zhu, Z., Lu, D., Kotanides, H., Santiago, A., Jimenez, X., Simcox, T., Hicklin, D. J., Böhlen, P., & Witte, L. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00324-3 · Cited by 49 · see citing works

Comparison of topical 0.7% dexamethasone–cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation

Saari, K. M., Nelimarkka, L., Ahola, V., et al. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0124-2 · Cited by 49 · see citing works

Efficacy and Tolerability of Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study in Adults and Children

Silverstein, B. E., Allaire, C., Bateman, K. M., et al. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.12.004 · Cited by 48 · see citing works

Contact lenses for antifungal ocular drug delivery: a review

Phan, C., Subbaraman, L. N., & Jones, L. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.882315 · Cited by 47 · see citing works

Challenges in Neuroprotective Nanomedicine Development: Progress Towards Noninvasive Gene Therapy of Glaucoma

Alqawlaq, S., Huzil, J. T., Ivanova, M. V., & Földvári, M. (2012) · Nanomedicine · doi:10.2217/nnm.12.69 · Cited by 47 · see citing works

In-vitro permeation of bevacizumab through human sclera: effect of iontophoresis application

Pescina, S., Ferrari, G., Govoni, P., et al. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01153.x · Cited by 46 · see citing works

In Vitro Evaluation of the Permeation Enhancing Effect of Polycarbophil–Cysteine Conjugates on the Cornea of Rabbits

Hornof, M., & Bernkop‐Schnürch, A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10258 · Cited by 46 · see citing works

Transcorneal Iontophoresis for Delivery of Ciprofloxacin Hydrochloride

Vaka, S. R. K., Sammeta, S. M., Day, L. B., & Murthy, S. N. (2008) · Current Eye Research · doi:10.1080/02713680802270945 · Cited by 46 · see citing works

Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases

Platania, C. B. M., Fisichella, V., Fidilio, A., Geraci, F., Lazzara, F., Leggio, G. M., Salomone, S., Drago, F., Pignatello, R., Caraci, F., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102076 · Cited by 45 · see citing works

Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats

Yafai, Y., Yang, X. M., Niemeyer, M., Nishiwaki, A., Lange, J., Wiedemann, P., King, A. G., Yasukawa, T., & Eichler, W. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.016 · Cited by 44 · see citing works

Corneal Penetration Behavior of β-Blocking Agents III: In Vitro–In Vivo Correlations

Lach, J. L., Huang, H.-S., & Schoenwald, R. D. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721110 · Cited by 44 · see citing works

The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration

Adams, C. M., Anderson, K., Artman, G. D., Bizec, J.-C., Cepeda, R., Elliott, J. M., Fassbender, E. S., Ghosh, M., Hanks, S. M., Hardegger, L. A., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01731 · Cited by 44 · see citing works

The Ocusert Pilocarpine System

Pollack, I. P., Quigley, H. A., & Harbin, T. S. (1976) · Southern Medical Journal · doi:10.1097/00007611-197610000-00013 · Cited by 43 · see citing works

Transcorneal Permeation in a Corneal Device of Non-Steroidal Anti-Inflammatory Drugs in Drug Delivery Systems

Valls, R., Vega, E., García, M. L., Egea, M. A., & Vall�s, J. (2008) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104500802010066 · Cited by 40 · see citing works

Ocular distribution, bactericidal activity and settling characteristics of TobraDex® ST ophthalmic suspension compared with TobraDex® ophthalmic suspension

Scoper, S. V., Kabat, A. G., Owen, G. R., et al. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0019-9 · Cited by 40 · see citing works

In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease

Rodriguez-Aller, M., Kaufmann, B., Guillarme, D., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.11.017 · Cited by 38 · see citing works

A water-soluble prodrug of cyclosporine A for ocular application: A stability study

Lallemand, F., Perottet, P., Felt-Baeyens, O., et al. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.003 · Cited by 38 · see citing works

Review of Azithromycin Ophthalmic 1% Solution (AzaSite®) for the Treatment of Ocular Infections

Opitz, D. L., & Harthan, J. (2012) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s7791 · Cited by 38 · see citing works

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema

Mayer, W. J., Remy, M., Wolf, A., et al. (2012) · Ophthalmologica · doi:10.1159/000338732 · Cited by 37 · see citing works

Effects of Aflibercept for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis of Observational Comparative Studies.

Zhang, Y., Chioreso, C., Schweizer, M. L., & Abràmoff, M. D. (2017) · PubMed Central · doi:10.1167/iovs.17-22471 · Cited by 37 · see citing works

Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report

Kelly, S. J., Hirani, A., Shahidadpury, V., Solanki, A., Halasz, K., Gupta, S. V., Madow, B., & Sutariya, V. B. (2018) · Biomedicines · doi:10.3390/biomedicines6030092 · Cited by 36 · see citing works

Alteration of retinal intrinsic survival signal and effect of α2–adrenergic receptor agonist in the retina of the chronic ocular hypertension rat

Kim, H. S., Chang, Y. I., Kim, J., & Park, C. K. (2007) · Visual Neuroscience · doi:10.1017/s0952523807070150 · Cited by 34 · see citing works

Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions

Suresh, P. K., & Sah, A. K. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.938045 · Cited by 33 · see citing works

Dose uniformity of ophthalmic suspensions

Diestelhorst, M., Kwon, K.-A., & Süverkrüp, R. (1998) · Journal of Cataract & Refractive Surgery · doi:10.1016/s0886-3350(98)80264-2 · Cited by 32 · see citing works

Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging

Molokhia, S. A., Jeong, E., Higuchi, W. I., et al. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.001 · Cited by 32 · see citing works

Role of Membrane Transporters and Metabolizing Enzymes in Ocular Drug Delivery

Vadlapatla, R. K., Vadlapudi, A. D., Pal, D., & Mitra, A. K. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666140926152459 · Cited by 31 · see citing works

Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis

Guo, D., Qin, L., Sun, Y., Guo, J., Zhao, Q., Yin, X., Wei, H., Wu, S., & Bi, H. (2019) · Nanotechnology · doi:10.1088/1361-6528/aafe36 · Cited by 31 · see citing works

Topically applied antibody fragments penetrate into the back of the rabbit eye

Williams, K. A., Brereton, H. M., Farrall, A. L., et al. (2004) · Eye · doi:10.1038/sj.eye.6701669 · Cited by 30 · see citing works

CLINICAL EVALUATION OF PAZOPANIB EYE DROPS IN HEALTHY SUBJECTS AND IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Singh, R. P., Wurzelmann, J. I., Ye, L., Henderson, L. S., Hossain, M. S., Trivedi, T., & Kelly, D. S. (2014) · Retina · doi:10.1097/iae.0000000000000179 · Cited by 30 · see citing works

PLGA nanoparticles for intravitreal peptide delivery: statistical optimization, characterization and toxicity evaluation

Bisht, R., & Rupenthal, I. D. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1240184 · Cited by 30 · see citing works

Encapsulated cells for long-term secretion of soluble VEGF receptor 1: Material optimization and simulation of ocular drug response

Kontturi, L.-S., Collin, E. C., Murtomäki, L. S., Pandit, A. S., Yliperttula, M. L., & Urtti, A. O. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.005 · Cited by 29 · see citing works

Rescue of Photoreceptors by BDNF Gene Transfer UsingIn VivoElectroporation in the RCS Rat of Retinitis Pigmentosa

Zhang, M., Mo, X., Fang, Y., Guo, W., Wu, J., Zhang, S., & Huang, Q. (2009) · Current Eye Research · doi:10.1080/02713680903086018 · Cited by 29 · see citing works

Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy

Mandal, A., Patel, M., Ye, S., et al. (2016) · Current Drug Targets · doi:10.2174/1389450117666151209115431 · Cited by 28 · see citing works

Nano-vectors for the ocular delivery of nucleic acid-based therapeutics

Khar, R. K., Warsi, M. H., Akhter, S., Ahmad, F., Jain, G. K., Mallick, N., & Pathan, S. (2010) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.84575 · Cited by 26 · see citing works

Effects of Dorzolamide Hydrochloride on Ocular Tissues

Inoue, J., Oka, M. T., Aoyama, Y., Kobayashi, S., Ueno, S., Hada, N., Takeda, T., & Takehana, M. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076804772745419 · Cited by 26 · see citing works

Role of Transporters in Ocular Drug Delivery System

Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9862-x · Cited by 25 · see citing works

Diffusion of Macromolecule Through Retina After Experimental Branch Retinal Vein Occlusion and Estimate of Intraretinal Barrier

Tao, Y. K., Li, X., Jiang, Y., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779815968 · Cited by 25 · see citing works

Ganciclovir implant in the treatment of cytomegalovirus retinitis

CHANG, M. A., & Dunn, J. P. (2005) · Expert Review of Medical Devices · doi:10.1586/17434440.2.4.421 · Cited by 25 · see citing works

Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases

Patel, S. P., Vaishya, R., Patel, A., et al. (2016) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1134685 · Cited by 23 · see citing works

Diffusion of macromolecules through sclera

Miao, H., Wu, B., Tao, Y. K., & Li, X. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02557.x · Cited by 21 · see citing works

Multi-Layered Nanomicelles as Self-Assembled Nanocarrier Systems for Ocular Peptide Delivery

Mandal, A., Patel, P., Pal, D., & Mitra, A. K. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1267-x · Cited by 21 · see citing works

Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters

Cholkar, K., Trinh, H. M., Vadlapudi, A. D., Wang, Z., Pal, D., & Mitra, A. K. (2015) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0144 · Cited by 19 · see citing works

Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug

Mandal, A., Pal, D., & Mitra, A. K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.027 · Cited by 19 · see citing works

Clear, Aqueous Topical Drop of Triamcinolone Acetonide

Trinh, H. M., Cholkar, K., Joseph, M. A., Yang, X., & Mitra, A. K. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0714-4 · Cited by 19 · see citing works

Delivery of Topically Applied Calpain Inhibitory Peptide to the Posterior Segment of the Rat Eye

Ozaki, T., Nakazawa, M., Yamashita, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130986 · Cited by 18 · see citing works

Novel Dexamethasone Sodium Phosphate Treatment (DSP-Visulex) for Noninfectious Anterior Uveitis: A Randomized Phase I/II Clinical Trial

Papangkorn, K., Truett, K. R., Vitale, A. T., et al. (2018) · Current Eye Research · doi:10.1080/02713683.2018.1540707 · Cited by 16 · see citing works

Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life.

McDonald, M. B., D’Aversa, G., Perry, H. D., et al. (2009) · PubMed · Cited by 15 · see citing works

Enhancement of transmucosal permeation of cyclosporine by benzalkonium chloride

van der Bijl, P., Eyk, A. D. V., Gareis, A., et al. (2002) · Oral Diseases · doi:10.1034/j.1601-0825.2002.01821.x · Cited by 14 · see citing works

A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue

Baranov, P. Y., Lin, H., McCabe, K. L., Gale, D. C., Cai, S., Lieppman, B., Morrow, D. M., Lei, P., Liao, J., & Young, M. J. (2017) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2016.0121 · Cited by 14 · see citing works

Pentablock Copolymer Dexamethasone Nanoformulations Elevate MYOC: In Vitro liberation, Activity and Safety in Human Trabecular Meshwork Cells

Agrahari, V., Li, G., Agrahari, V., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0140 · Cited by 13 · see citing works

Eye-concentrated distribution of dexamethasone carried by sugar-chain modified liposome in experimental autoimmune uveoretinitis mice

Arakawa, Y., Hashida, N., Ohguro, N., et al. (2007) · Biomedical Research · doi:10.2220/biomedres.28.331 · Cited by 9 · see citing works

Synthesis and binding monitoring of a new nanomolar PAMAM-based matrix metalloproteinases inhibitor (MMPIs)

Cerofolini, L., Baldoneschi, V., Dragoni, E., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.11.028 · Cited by 9 · see citing works

Hyaluronic acid in ocular drug delivery

Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196 · see citing works

Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions

Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145 · see citing works

Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges

Vázquez-Domínguez, I., Garanto, A., & Collin, R. W. J. (2019) · Genes · doi:10.3390/genes10090654 · Cited by 80 · see citing works

Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: synthesis, in vitro/vivo evaluation, and mechanism

Sun, X., Sheng, Y., Li, K., Sai, S., Feng, J., Li, Y., Zhang, J., Han, J., & Tian, B. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.10.047 · Cited by 79 · see citing works

Ocular drug delivery: advancements and innovations

Tian, B., Bilsbury, E., Doherty, S., Teebagy, S., Wood, E., Su, W., Gao, G., & Lin, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091931 · Cited by 50 · see citing works

Self-assembling tacrolimus nanomicelles for retinal drug delivery

Gote, V., Mandal, A., Alshamrani, M., & Pal, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111072 · Cited by 39 · see citing works

Micelles of progesterone for topical eye administration: interspecies and intertissues differences in Ex vivo ocular permeability

Alambiaga-Caravaca, A. M., Calatayud-Pascual, M. A., Rodilla, V., Concheiro, A., López-Castellano, A., & Alvarez-Lorenzo, C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080702 · Cited by 38 · see citing works

Engineered bio-adhesive polyhedral oligomeric silsesquioxane hybrid nanoformulation of amphotericin B for prolonged therapy of fungal keratitis

Han, Y., Xu, C., Shi, H., Yu, F., Zhong, Y., Liu, Z., Loh, X. J., Wu, Y.-L., Li, Z., & Li, C. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129734 · Cited by 30 · see citing works

From design to Deployment: The innovative role of nanomicelles in targeted ophthalmic therapeutics

Sun, M., Wang, J., Fan, W., Wang, K., Wang, Y., Zhang, J., Ding, S., Zhang, C., Feng, Z., Wang, Y.-G., et al. (2025) · Materials today. Bio · doi:10.1016/j.mtbio.2025.102537 · Cited by 7 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Evaluation of posterior segment ocular disorders using B-scan ultrasonography in patients attending a tertiary care teaching hospital Telangana India

Sujatha, G., Krishna, N., Vasantha, G., et al. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns8.12947

People's Drug Guide to Deadly Drug Interactions Focuses on Drug/Drug, Drug/Food, and Drug/Vitamin Interactions

(1998) · Gastroenterology Nursing · doi:10.1097/00001610-199805000-00012

Me-too drug,me-better drug and me-new drug in drug R&D

Bao-quan, Z. (2009) · Zhongguo xin yao zazhi

Clinical Drug–Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access

Rekić, D., Reynolds, K. S., Zhao, P., Zhang, L., Yoshida, K. J., Sachar, M., Piquette‐Miller, M., Huang, S. M., & Zineh, I. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.016 · Cited by 65 · see citing works